Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for memory improvement in children and adolescents with idiopathic epilepsy
PACTR202602685773069Not yet recruiting
- Sponsor
- Self sponsor
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of memantine in idiopathic epilepsy (IGE) (3 arms), sponsored by Self sponsor. Primary endpoint: Working and visual memory improvement. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
memantine
03
Conditions
idiopathic epilepsy (IGE)
Beyond the preview
Go deeper on PACTR202602685773069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602685773069.